CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Equity Consideration Payable	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)	Treasury Stock
Beginning balance (in shares) at Dec. 31, 2024		40,188,000
Beginning balance at Dec. 31, 2024	$ 871,710	$ 798	$ 1,085,473	$ 108,182	$ (279,943)	$ (20,951)	$ (21,849)
Treasury stock, beginning balance (in shares) at Dec. 31, 2024							1,470,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon the exercise of stock options (in shares)		8,000
Issuance of common stock upon the exercise of stock options	215		215
Net issuance of restricted stock awards and restricted stock units (in shares)		382,000
Net issuance of restricted stock awards and restricted stock units	0	$ 6	(6)
Issuance of common stock for acquisition (in shares)		1,489,000
Issuance of common stock for acquisition	0	$ 29	108,153	(108,182)
Treasury stock acquired from employees upon vesting or forfeiture of restricted stock (in shares)							102,000
Treasury stock acquired from employees upon vesting or forfeiture of restricted stock	(7,015)						$ (7,015)
Stock-based compensation	7,181		7,181
Foreign currency translation adjustments	4,254					4,254
Net loss	(24,350)				(24,350)
Ending balance (in shares) at Mar. 31, 2025		42,067,000
Ending balance at Mar. 31, 2025	$ 851,995	$ 833	1,201,016	0	(304,293)	(16,697)	$ (28,864)
Treasury stock, ending balance (in shares) at Mar. 31, 2025							1,572,000
Beginning balance (in shares) at Dec. 31, 2025	40,653,932	42,227,000
Beginning balance at Dec. 31, 2025	$ 825,150	$ 836	1,226,039	0	(364,404)	(8,429)	$ (28,892)
Treasury stock, beginning balance (in shares) at Dec. 31, 2025	1,572,833						1,573,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon the exercise of stock options (in shares)	5,000	5,000
Issuance of common stock upon the exercise of stock options	$ 54		54
Net issuance of restricted stock awards and restricted stock units (in shares)		382,000
Net issuance of restricted stock awards and restricted stock units	0	$ 8	(8)
Issuance of common stock for acquisition (in shares)		1,810,000
Issuance of common stock for acquisition	24,836	$ 36	24,800
Repurchase of common stock (in shares)		(2,090,000)
Repurchase of common stock	(33,125)	$ (42)	(33,083)
Issuance of common stock for conversion of notes (in shares)		485,000
Issuance of common stock for conversion of notes	20,567	$ 10	20,557
Stock-based compensation	7,203		7,203
Foreign currency translation adjustments	(2,089)					(2,089)
Net loss	$ (16,169)				(16,169)
Ending balance (in shares) at Mar. 31, 2026	41,246,199	42,819,000
Ending balance at Mar. 31, 2026	$ 826,427	$ 848	$ 1,245,562	$ 0	$ (380,573)	$ (10,518)	$ (28,892)
Treasury stock, ending balance (in shares) at Mar. 31, 2026	1,572,833						1,573,000